## NDAQ: Nasdaq, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.47 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($90.39)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. State Street Corp Reduces Stock Position in Nasdaq, Inc. $NDAQ**
- Source: MarketBeat | 20251211T122037 | Somewhat-Bullish | Relevance: 100%
- State Street Corp recently decreased its stake in Nasdaq, Inc. by 0.6% during the second quarter, now holding 18,214,844 shares valued at over $1.6 billion. While State Street reduced its position, other hedge funds like Cary Street Partners Investment Advisory LLC and Leavell Investment Management Inc. increased their holdings in Nasdaq. Despite the reduction from State Street, institutional investors and hedge funds collectively own a significant 72.47% of Nasdaq's stock, and analysts maintain a "Moderate Buy" rating with a consensus price target of $101.00.

**2. Analysts Conflicted on These Financial Names: Figure Technology Solutions, Inc. Class A (FIGR) and Nasdaq (NDAQ)**
- Source: The Globe and Mail | 20251211T140746 | Somewhat-Bullish | Relevance: 100%
- Analysts have provided conflicting ratings for two financial sector companies: Figure Technology Solutions, Inc. Class A (FIGR) and Nasdaq (NDAQ). A Bank of America Securities analyst maintained a Hold rating on FIGR, while another analyst from the same firm issued a Buy rating for NDAQ. The consensus among analysts indicates a Moderate Buy for FIGR with a 24.3% upside and a Strong Buy for NDAQ with a 19.8% upside.

**3. Nasdaq Verafin Joins Global Anti-Scam Alliance**
- Source: ACCESS Newswire | 20251210T140947 | Bullish | Relevance: 97%
- Nasdaq Verafin has joined the Global Anti-Scam Alliance (GASA) as a Foundation Member, strengthening global efforts against scams, financial crime, and digital fraud. This partnership will extend to GASA's Brazil and Mexico chapters, leveraging Nasdaq Verafin's expertise in financial crime management technology to develop innovative defense strategies. The collaboration aims to enhance trust, transparency, and resilience in financial ecosystems, especially in vulnerable regions like Mexico and Brazil.

**4. Annual Changes to the Nasdaq-100 Index®**
- Source: The Globe and Mail | 20251213T015952 | Neutral | Relevance: 81%
- Nasdaq announced the annual reconstitution of the Nasdaq-100 Index®, effective December 22, 2025. Six companies will be added, including Alnylam Pharmaceuticals and Western Digital Corp., while six others, such as Biogen Inc. and Lululemon Athletica Inc., will be removed. The Nasdaq-100 Index tracks 100 of the largest non-financial companies on the Nasdaq Stock Market and underpins over 200 tracking products with more than $600 billion in assets under management.

**5. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20251210T110809 | Neutral | Relevance: 74%
- JPMorgan Chase Financial Company LLC is offering Structured Investments Auto Callable Contingent Interest Notes, fully and unconditionally guaranteed by JPMorgan Chase & Co. These notes are linked to the performance of the Nasdaq-100® Technology Sector Index SM, the Russell 2000® Index, and the S&P 500® Index, and are designed for investors seeking contingent interest payments but willing to risk principal loss. The notes may be automatically called if each index performs above its initial value on certain review dates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $114 | $109 | +5% |
| 2025-11-20 | Morgan Stanley | $110 | $97 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Overweight |
| 2025-11-20 | Morgan Stanley | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+6.9%)
- Investor AB: 10.2% (0.0%)
- Blackrock Inc.: 7.0% (+8.3%)
- Wellington Managemen: 7.0% (-3.5%)
- Massachusetts Financ: 4.6% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.47 suggests fair value with growth premium. Forward P/E 24.5x stretched relative to 11% growth. Quality metrics strong (margin 20%). Analyst sentiment positive (2 raises, avg +9%). Insider selling cluster ($2.8M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $53.7B |
| Beta | 1.02 |
| 52W Range | $64.84 - $97.63 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.47 |
| Forward P/E | 24.5 |
| Current P/E | 27.3 |
| YoY Growth | 11.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.3% to 4.6% (+4.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 72nd percentile. MRS_5 at 3.1% confirms short-term momentum alignment. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.54), confirming momentum. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.56% (CS: 72) | Strong |
| RSI_14 | 67.8 | Neutral |
| MACD Histogram | 0.54 | Bullish |
| vs SMA20 | 1.049x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.091x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $93.57
- **Stop Loss:** $90.39 (3.4% risk)
- **Target:** $99.93 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 377
- **Position Value:** $35,275.89
- **Portfolio %:** 35.28%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.88 | +3.7% |
| 2025Q2 | $0.81 | $0.85 | +4.6% |
| 2025Q1 | $0.77 | $0.79 | +2.5% |
| 2024Q4 | $0.75 | $0.76 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*